GE HealthCare (Nasdaq:GEHC) shares ticked up today on third-quarter results that came in mixed compared to the consensus forecast.

GE HealthCare（Nasdaq:GEHC）股价今日上涨，第三季度业绩与普遍预测相比喜忧参半。

Shares of GEHC rose 1% to $86.08 apiece in mid-morning trading today.

GEHC的股价在今天上午中午的交易中上涨1%，至每股86.08美元。

The Chicago-based company reported profits of $470 million. That equals $1.02 per share on sales of $4.86 billion for the three months ended Sept. 30, 2024.

这家总部位于芝加哥的公司报告利润为4.7亿美元。这相当于截至2024年9月30日的三个月内每股销售额48.6亿美元的1.02美元。

GE HealthCare recorded a 25.3% bottom-line gain on a sales increase of 0.85%.

GE HealthCare在销售额增长0.85%的基础上实现了25.3%的底线增长。

Adjusted to exclude one-time items, earnings per share came in at $1.14. That landed 9¢ ahead of estimates on Wall Street. Sales came up just shy of expectations, though, as experts projected $4.87 billion in revenue.

排除一次性项目后，每股收益为1.14美元。这比华尔街的估计高出9美分。尽管如此，销售额还是低于预期，因为专家预测收入为48.7亿美元。

One area GE HealthCare highlighted was headwinds in China, which the company noted last quarter as well. Both Philips and Intuitive Surgical also recently highlighted issues in the Chinese medtech market in their latest earnings reports, indicating that it could have broader implications for the industry..

GE HealthCare强调的一个领域是中国的逆风，该公司上个季度也注意到了这一点。飞利浦和直觉外科（Intuitive Surgical）最近在最新的盈利报告中也强调了中国医疗技术市场的问题，表明这可能对该行业产生更广泛的影响。。

“Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments,” GE HealthCare President and CEO Peter Arduini said. “Ongoing lean initiatives across the organization are delivering better value to patients and customers and have resulted in robust margin expansion.”.

GE HealthCare总裁兼首席执行官彼得·阿杜尼（PeterArduini）表示：“除中国外，销售额和订单均以中个位数的速度增长，在美国的所有细分市场都有特别的优势。”。“整个组织正在进行的精益计划正在为患者和客户提供更好的价值，并带来了强劲的利润增长。”。

GE HealthCare expects revenue growth to end up near the lower end of its previously announced 1%-2% projection. The company attributed this to the continued market softness in China. However, GE HealthCare raised the low end of its adjusted EPS guidance from $4.20 to $4.25, meaning it now projects between $4.25 and $4.35..

GE HealthCare预计收入增长率将接近之前公布的1%-2%的预测下限。该公司将此归因于中国市场持续疲软。然而，GE HealthCare将其调整后每股收益指导值的低端从4.20美元上调至4.25美元，这意味着它现在预计的每股收益在4.25美元至4.35美元之间。。